These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33741703)

  • 61. Continuous Glucose Monitoring Time-in-Range and HbA
    Tundidor D; Meek CL; Yamamoto J; Martínez-Bru C; Gich I; Feig DS; Murphy HR; Corcoy R;
    Diabetes Technol Ther; 2021 Oct; 23(10):710-714. PubMed ID: 33945304
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
    Diabetes Care; 2010 May; 33(5):1004-8. PubMed ID: 20200306
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Centralized Remote Monitoring of Continuous Glucose Monitoring Data at Diabetes Camp Mitigates Hypoglycemia.
    Gleich S; Gibson N; Puhr S; Walker TC; Caruso D
    J Diabetes Sci Technol; 2021 Jul; 15(4):962-964. PubMed ID: 33955245
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Continuous glucose monitoring and type 1 diabetes.
    Finlayson AE; Cronin NJ; Choudhary P
    N Engl J Med; 2009 Jan; 360(2):191; author reply 191-2. PubMed ID: 19137629
    [No Abstract]   [Full Text] [Related]  

  • 66. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes.
    Bergenstal RM; Mullen DM; Strock E; Johnson ML; Xi MX
    J Diabetes Complications; 2022 Mar; 36(3):108106. PubMed ID: 35131155
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study.
    Picard S; Hanaire H; Reznik Y; Benhamou PY; Fendri S; Dufaitre L; Leutenegger E; Guerci B
    Diabetes Technol Ther; 2018 Jun; 20(6):403-412. PubMed ID: 29847735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners.
    Ajjan R; Slattery D; Wright E
    Adv Ther; 2019 Mar; 36(3):579-596. PubMed ID: 30659511
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of Education on Impaired Hypoglycemia Awareness and Glycemic Variability in Children and Adolescents with Type 1 Diabetes Mellitus.
    Demir G; Özen S; Çetin H; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):189-195. PubMed ID: 30701953
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sustained Intensive Treatment and Long-term Effects on HbA
    Lind M; Ólafsdóttir AF; Hirsch IB; Bolinder J; Dahlqvist S; Pivodic A; Hellman J; Wijkman M; Schwarcz E; Albrektsson H; Heise T; Polonsky W
    Diabetes Care; 2021 Jan; 44(1):141-149. PubMed ID: 33199470
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
    Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
    BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
    Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
    [No Abstract]   [Full Text] [Related]  

  • 74. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring.
    Jackson MA; Ahmann A; Shah VN
    Diabetes Technol Ther; 2021 Mar; 23(S1):S27-S34. PubMed ID: 33534631
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Real-time continuous glucose monitoring in randomized control trials.
    Battelino T; Phillip M
    Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():401-4. PubMed ID: 20877253
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
    Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
    J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial.
    Renard E; Riveline JP; Hanaire H; Guerci B;
    Diabetes Obes Metab; 2022 May; 24(5):859-867. PubMed ID: 34984786
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incongruent Changes in Lab HbA1c and Average Glucose Underscore Significant Differences in Calibration Between Continuous Glucose Monitoring Systems During the Conduct of a Study on Glycemic Control in Type 1 Diabetes-Comment on Préau et al.
    Seibold A
    Diabetes Technol Ther; 2021 Aug; 23(8):595-597. PubMed ID: 33710915
    [No Abstract]   [Full Text] [Related]  

  • 79. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods.
    JDRF CGM Study Group
    Diabetes Technol Ther; 2008 Aug; 10(4):310-21. PubMed ID: 18828243
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.
    Oliver N; Gimenez M; Calhoun P; Cohen N; Moscardo V; Hermanns N; Freckmann G; Reddy M; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):53-58. PubMed ID: 31530662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.